Literature DB >> 16821764

Discovery of novel triazole-based opioid receptor antagonists.

Qiang Zhang1, Susan M Keenan, Youyi Peng, Anil C Nair, Seong Jae Yu, Richard D Howells, William J Welsh.   

Abstract

We report the computer-aided design, chemical synthesis, and biological evaluation of a novel family of delta opioid receptor (DOR) antagonists containing a 1,2,4-triazole core structure that are structurally distinct from other known opioid receptor active ligands. Among those delta antagonists sharing this core structure, 8 exhibited strong binding affinity (K(i) = 50 nM) for the DOR and appreciable selectivity for delta over mu and kappa opioid receptors (delta/mu = 80; delta/kappa > 200).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16821764      PMCID: PMC2693423          DOI: 10.1021/jm0601250

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  30 in total

Review 1.  Molecular mechanisms and regulation of opioid receptor signaling.

Authors:  P Y Law; Y H Wong; H H Loh
Journal:  Annu Rev Pharmacol Toxicol       Date:  2000       Impact factor: 13.820

2.  delta Opioid affinity and selectivity of 4-hydroxy-3-methoxyindolomorphinan analogues related to naltrindole.

Authors:  A Coop; R B Rothman; C Dersch; J Partilla; F Porreca; P Davis; A E Jacobson; K C Rice
Journal:  J Med Chem       Date:  1999-05-06       Impact factor: 7.446

3.  Enrichment of ligands for the serotonin receptor using the Shape Signatures approach.

Authors:  Karthigeyan Nagarajan; Randy Zauhar; William J Welsh
Journal:  J Chem Inf Model       Date:  2005 Jan-Feb       Impact factor: 4.956

4.  3D-QSAR comparative molecular field analysis on opioid receptor antagonists: pooling data from different studies.

Authors:  Youyi Peng; Susan M Keenan; Qiang Zhang; Vladyslav Kholodovych; William J Welsh
Journal:  J Med Chem       Date:  2005-03-10       Impact factor: 7.446

Review 5.  Opioids: old drugs for potential new applications.

Authors:  U Barry; Z Zuo
Journal:  Curr Pharm Des       Date:  2005       Impact factor: 3.116

6.  Physiological control of emotion-related behaviors by endogenous enkephalins involves essentially the delta opioid receptors.

Authors:  M Mas Nieto; S L E Guen; B L Kieffer; B P Roques; F Noble
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

Review 7.  Bivalent ligands and the message-address concept in the design of selective opioid receptor antagonists.

Authors:  P S Portoghese
Journal:  Trends Pharmacol Sci       Date:  1989-06       Impact factor: 14.819

8.  SNC 80, a selective, nonpeptidic and systemically active opioid delta agonist.

Authors:  E J Bilsky; S N Calderon; T Wang; R N Bernstein; P Davis; V J Hruby; R W McNutt; R B Rothman; K C Rice; F Porreca
Journal:  J Pharmacol Exp Ther       Date:  1995-04       Impact factor: 4.030

9.  Copper-mediated cross-coupling of functionalized arylmagnesium reagents with functionalized alkyl and benzylic halides.

Authors:  W Dohle; D M Lindsay; P Knochel
Journal:  Org Lett       Date:  2001-09-06       Impact factor: 6.005

10.  Novel ligands lacking a positive charge for the delta- and mu-opioid receptors.

Authors:  P W Schiller; I Berezowska; T M Nguyen; R Schmidt; C Lemieux; N N Chung; M L Falcone-Hindley; W Yao; J Liu; S Iwama; A B Smith; R Hirschmann
Journal:  J Med Chem       Date:  2000-02-24       Impact factor: 7.446

View more
  5 in total

1.  Identification of previously unrecognized antiestrogenic chemicals using a novel virtual screening approach.

Authors:  Ching Y Wang; Ni Ai; Sonia Arora; Eric Erenrich; Karthigeyan Nagarajan; Randy Zauhar; Douglas Young; William J Welsh
Journal:  Chem Res Toxicol       Date:  2006-12       Impact factor: 3.739

2.  Highly potent triazole-based tubulin polymerization inhibitors.

Authors:  Qiang Zhang; Youyi Peng; Xin I Wang; Susan M Keenan; Sonia Arora; William J Welsh
Journal:  J Med Chem       Date:  2007-01-24       Impact factor: 7.446

3.  Synthesis and spectroscopic properties of new azo dyes derived from 3-ethylthio-5-cyanomethyl-4-phenyl-1,2,4-triazole.

Authors:  Mariam Al-Sheikh; Hanadi Y Medrasi; Kamal Usef Sadek; Ramadan Ahmed Mekheimer
Journal:  Molecules       Date:  2014-03-07       Impact factor: 4.411

Review 4.  Identification of an irreversible PPARγ antagonist with potent anticancer activity.

Authors:  Youyi Peng; Qiang Zhang; Robert M Zielinski; Richard D Howells; William J Welsh
Journal:  Pharmacol Res Perspect       Date:  2020-12

5.  The Intriguing Effects of Substituents in the N-Phenethyl Moiety of Norhydromorphone: A Bifunctional Opioid from a Set of "Tail Wags Dog" Experiments.

Authors:  Meining Wang; Thomas C Irvin; Christine A Herdman; Ramsey D Hanna; Sergio A Hassan; Yong-Sok Lee; Sophia Kaska; Rachel Saylor Crowley; Thomas E Prisinzano; Sarah L Withey; Carol A Paronis; Jack Bergman; Saadet Inan; Ellen B Geller; Martin W Adler; Theresa A Kopajtic; Jonathan L Katz; Aaron M Chadderdon; John R Traynor; Arthur E Jacobson; Kenner C Rice
Journal:  Molecules       Date:  2020-06-06       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.